DOXORUBICIN INDUCED NEURO- AND CARDIOTOXICITIES IN EXPERIMENTAL RATS: PROTECTION AGAINST OXIDATIVE DAMAGE BY THEOBROMA CACAO STEM BARK

Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2017, Vol 4, Issue 4

Abstract

80 rats, randomly selected, were divided into 3 treatment groups: pre-, co- and post-treatment; consisting of 6 sub-groups each (5 rats per sub-group): baseline, normal saline (2 mL), α-lipoic acid (20 mg/kg body weight), 200 mg/kg, 400 mg/kg or 800 mg/kg body weight Theobroma cacao stem bark aqueous extract (TCAE). All rats except for baseline group were intoxicated with 20mg/kg body weight doxorubicin (DOX) intraperitoneally. The animals in pre- or post-treatment group received a single dose of DOX (20 mg/kg body weight) intraperitoneally 24h before or after 7 days’ oral administration with TCAE respectively while those in co-treatment group were co-administered 2.86 mg/kg body weight of DOX with either normal saline, α- lipoic acid or TCAE orally for 7 days. Animals were sacrificed (pre- and post- treatment groups were sacrificed on the ninth day while the co-treatment group sacrificed on the 8th day). Brain and heart tissue samples were harvested for enzyme markers of toxicity, oxidative stress and histopathological examinations. DOX intoxication caused significant decrease in activities of LDH and ACP, and increase in γGT and ALP activities in brain tissues while causing a significant increase in LDH, ACP, γGT activities and decrease in ALP activity in the cardiac tissues. DOX intoxication caused a significant increase in concentrations of H2O2 generated, MDA and PC, XO, MPx and NOX activities with concomitant decrease in CAT, SOD, GPx and GST activities, and in concentrations of GSH, AsA and α-Toc in brain and cardiac tissues. Pre-, co- and post-treatment with TCAE at either 200 mg/kg, 400 mg/kg or 800 mg/kg body weight significantly reversed the oxidative damage to the organs induced by DOX-intoxication. The result affirmed that T. cacao stem bark aqueous extract protected against DOX induced oxidative damage in brain and cardiac tissues of experimental rats.

Authors and Affiliations

Kosoko A. M.

Keywords

Related Articles

VISUAL FINDINGS IN NEOVASCULAR MACULAR DEGENERATION REFRACTORY TO BEVACIZUMAB AFTER INTRAVITREAL AFLIBERCEPT THERAPY

Neovascular (wet) age-related macular degeneration (AMD) is associated with blindness in patient populations above 55 years of age, affecting approximately 2 million Americans. Intravitreal (IV) bevacizumab is widely emp...

GENOTYPIC CHARACTERIZATION OF ANTIBIOTICS RESISTANCE INTEGRONS IN EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCING STRAINS OF E. COLI AND PROTEUS SPP. IN OUAGADOUGOU, BURKINA FASO

Introduction: During the 1980s, genetic elements that could acquire or lose genes for antibiotic resistance were identified and referred to as integrons. The aim of this study was to genotypically characterize integron i...

EFFECT OF CHOLECYSTECTOMY ON SERUM LIPID PROFILE PRE AND POST OPERATION

Background: The objective of this study was to examine changes in body mass index (BMI). and to determine the changes in lipid profile parameters in three stages: preoperative, postoperative and long periods for cholecys...

EXTRACORPORAL IMMUNOPHARMACOTHERAPY IN COMPLEX TREATMENT OF CERVICAL CANCER AND OVAR CANCER

When prescribing EIPHT methods for patients with cervical cancer and OC, the results of clinical and diagnostic studies, anamnestic data, the presence of specific antitumor or nontraditional types of treatment before adm...

TREATMENT OF PATIENTS WITH GASTRIC CANCER LIVER METASTASES

Despite of steady decline in the incidence of gastric cancer (GC), for many countries, this pathology remains one of the most important medical and socio-economic problems.[1,2,3,5] Analysis of mortality data in 24 econo...

Download PDF file
  • EP ID EP628960
  • DOI -
  • Views 160
  • Downloads 0

How To Cite

Kosoko A. M. (2017). DOXORUBICIN INDUCED NEURO- AND CARDIOTOXICITIES IN EXPERIMENTAL RATS: PROTECTION AGAINST OXIDATIVE DAMAGE BY THEOBROMA CACAO STEM BARK. European Journal of Pharmaceutical and Medical Research, 4(4), 45-66. https://europub.co.uk/articles/-A-628960